Skip to main content

Incontinence, Urge

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Laborie
LaborieNH - Portsmouth
2 programs
TDOC 5FrN/A1 trial
TDOC NXTN/A1 trial
Active Trials
NCT03429270Completed28Est. Oct 2018
NCT03615001Completed20Est. Oct 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
LaborieTDOC NXT
LaborieTDOC 5Fr

Clinical Trials (2)

Total enrollment: 48 patients across 2 trials

T-DOC® NXT Clinical Investigation

Start: Jul 2018Est. completion: Oct 201820 patients
N/ACompleted

T-DOC® 5 Fr Pediatric Clinical Investigation

Start: Jan 2018Est. completion: Oct 201828 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.